Beth Seidenberg, Director at Epizyme, holds 735.98K shares in Kyverna Therapeutics, Inc. (Ticker: KYTX), holds 2.03M shares in Sagimet Biosciences, Inc. Class A (Ticker: SGMT), holds 5.34M shares in Progyny (Ticker: PGNY).
Beth Seidenberg latest transaction was an Uninformative Buy of ―.
What was Beth Seidenberg's most profitable transaction?
Beth Seidenberg’s most profitable transaction was an Informative Buy of VERA stock on February 27, 2023. The return on the trade was 546.10%.
What is Beth Seidenberg's role in Epizyme?
Beth Seidenberg's role in Epizyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.